| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V23153 | KB-141 | 219691-94-8 | KB-141 is a potent and specific TRβ agonist. |
|
V23154 | KB-74935 | 946398-78-3 | KB-74935 is a novel and potent bioactive compound |
|
V23155 | KBG 4 | 63811-80-3 | KBG 4 is a novel and potent bioactive compound |
|
V20596 | KBH-A42 | 798543-50-7 | KBH-A42 is a novel and potent histone deacetylase inhibitor |
|
V23156 | KBP-7018 | 1613437-66-3 | KBP-7018 is a selective inhibitor of tyrosine kinases. |
|
V23157 | KBP-7018 HCl | 1613437-67-4 | KBP-7018 HCl is a novel and potent tyrosine kinase inhibitor |
|
V23158 | KBR 2822 | 126988-60-1 | KBR 2822 is a novel and potent esterase inhibitor |
|
V23159 | KBU2046 | 1143863-69-7 | KBU2046 is an orally bioactive, selective inhibitor of cell motility and invasion in vitro. |
|
V23160 | KC 400 | 12737-87-0 | KC 400 is a novel and potent mixture of polychlorinated biphenyls |
|
V27848 | KC-11 | KC-11 is a novel and potent inhibitor of mtb-dhfr | |
|
V23163 | KC-12615 | 182821-29-0 | KC-12615 is a novel and potent endopeptidase inhibitior |
|
V23161 | KC01 | 1646795-59-6 | KC01 is a potent inhibitor of ABHD16A, with IC50 of 90 nM for hABHD16A and IC50 of 520 nM for mABHD16A; KC01 significantly reduces lyso-PSs, thereby reducing lyso-PS and lipopolysaccharide-induced cell death in mouse macrophages. |
|
V23164 | KCA-1490 | 909719-71-7 | KCA-1490 is a novel and potent PDE3/4 inhibitor |
|
V6433 | KCC009 | 744198-19-4 | KCC009 is a novel, potent and selective inhibitor of Transglutaminase 2, it is able to disrupt fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. |
|
V23166 | KCG 1 | 139036-51-4 | KCG 1 is a novel and potent keto-C-glycoside drug |
|
V23167 | KCN1 | 927823-01-6 | KCN1 is a novel and potent HIF pathway inhibitor |
|
V23168 | KCO-912 | 185695-83-4 | KCO-912 is a novel and potent ATP-dependent K channel opener |
|
V21896 | KD-026 | 913541-47-6 | SLX-4090, an orally bioactive, enterocyte-specific microsomal triglyceride transfer protein (MTP) inhibitor (antagonist) with IC50 of 8.0 nM. |
|
V18974 | KD-027 | 906421-01-0 | KD-027 (SLx-2101;KD 027; SLx 2101;KD027; SLx2101) is a novel and potent PDE5A inhibitor with potential anti-hypertensive activity. |
|
V23171 | KDM4-IN-I | 23705-85-3 | KDM4-IN-I is a novel and potent KDM4 inhibitor |